Roxana S. Dronca, M.D. - Clinical Trial Investigator | Syfrah

Trials Sponsors Conditions Drugs Pricing

Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(3)

DRUG(1)

OTHER(1)

Patient Monitoring

Questionnaire Administration

Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta and Tyrosinase Related Protein 1

Home Health Encounter

5 unique interventions3 categories

Analytics

Trial Phases

Phase 11

Phase 21

Trial Status

Recruiting1

Terminated1

Role Distribution

Principal Investigator2

PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06265285Phase 2Recruiting

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more

PrincipalinvestigatorStart date: 2024-04-30

NCT03865212Phase 1Terminated

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Choroid Melanoma+10 more

PrincipalinvestigatorStart date: 2019-06-12

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

CO

High-influence Collaborator

CO

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Clinical Stage III Cutaneous Melanoma AJCC v82 Clinical Stage IV Cutaneous Melanoma AJCC v82 Advanced Esophageal Squamous Cell Carcinoma1 Advanced Renal Cell Carcinoma1 Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v81 Clinical Stage IIB Cutaneous Melanoma AJCC v81 Clinical Stage IIC Cutaneous Melanoma AJCC v81 Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v81

Affiliations

Mayo Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Aung Naing, Md

M.D. Anderson Cancer Center

Shared therapeutic areas:

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Melanoma+9 more

Similarity Score9%

Rahul Aggarwal, MD

University of California, San Francisco

Shared therapeutic areas:

Metastatic Urothelial CarcinomaAdvanced Renal Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma+4 more

Similarity Score5%

Michael B Gill

Power Life Sciences Inc.

Shared therapeutic areas:

Carcinoma, HepatocellularCarcinoma, Renal Cell

Similarity Score1%

David Avigan, MD

Beth Israel Deaconess Medical Center

Shared therapeutic areas:

Carcinoma, Renal CellMetastatic Melanoma

Similarity Score1%

Heinz-Josef Lenz, MD

University of Southern California

Shared therapeutic areas:

Stage IV Colorectal Cancer AJCC v8

Similarity Score1%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Shared therapeutic areas:

Metastatic Melanoma

Similarity Score1%

Jeong Min Lee, MD

Seoul National University Hospital

Shared therapeutic areas:

Carcinoma, Hepatocellular

Similarity Score1%

Murad Alam, MD

Northwestern University

Shared therapeutic areas:

Metastatic Melanoma

Similarity Score1%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Shared therapeutic areas:

Metastatic Melanoma

Similarity Score1%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Shared therapeutic areas:

Carcinoma, Renal Cell

Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06265285Phase 2PrincipalInvestigator

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more

Recruiting

NCT03865212Phase 1PrincipalInvestigator

Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma

Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Choroid Melanoma+10 more

Terminated

All 2 trials loaded